ERYTECH Pharma (ERYP) IPO Opens 15% Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Erytech Announces Trading Resumption of Its Ordinary Shares on Euronext Paris
November 10, 2017 10:01 AM ESTLYON, France--(BUSINESS WIRE)--
Regulatory News:
NOT FOR DISTRIBUTION IN AUSTRALIA, CANADA OR JAPAN
ERYTECH Pharma (Paris: ERYP) (ADR: EYRYY) (Euronext Paris: ERYP) (ERYTECH or the Company) announces trading resumption of its ordinary shares on Euronext Paris as from 4:00pm CET.
Trading in the ordinary shares of ERYTECH Pharma was suspended at the request of the Company on November 10, 2017 from 9:00 am CET in connection with its previously announced global offering in order to... More
ERYTECH Announces Pricing of Global Offering and Approval to List on Nasdaq Global Select Market
November 10, 2017 8:06 AM ESTLYON, France--(BUSINESS WIRE)-- Regulatory News:
NOT FOR DISTRIBUTION IN AUSTRALIA, CANADA AND JAPAN
ERYTECH Pharma (Paris: ERYP) (ADR: EYRYY) ("ERYTECH" or the "Company"), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced the pricing of its global offering to specified categories of investors of an aggregate of 5,374,033 new ordinary shares, comprising an offer of 4,686,106 ordinary shares in the form of American Depositary Shares, each representing one ordinary share ("ADSs"), in the... More
ERYTECH Announces Trading Suspension of Its Ordinary Shares on Euronext Paris
November 10, 2017 2:18 AM ESTLYON, France--(BUSINESS WIRE)--
Regulatory News:
NOT FOR DISTRIBUTION IN AUSTRALIA, CANADA OR JAPAN
Trading in the ordinary shares of ERYTECH Pharma (Euronext Paris: ERYP) (ERYTECH or the Company) (Paris: ERYP) (ADR: EYRYY), was suspended at the request of the Company on November 10, 2017 from 9:00 am CET in connection with its previously announced global offering in order to allow for the confirmation of allocations to investors and for the commencement of trading of the Companys American Depositary Shares (ADSs) on the Nasdaq Global... More
